Materia, the mother company of Materia Malta, announced that it has commenced sales of the first medical cannabis flower produced at its EU GMP certified manufacturing site.
‘Carbasi Verde’, the company’s inaugural product, can now be purchased from pharmacies all over the islands and will be shipped out to Germany and the UK.
“The journey began in earnest over two years ago, so we’re elated to be offering patients Materia manufactured and branded medical cannabis,” Materia’s Europe Managing Director, Nick Pateras, said.
“Out Maltese site is truly state-of-the-art, and with our team’s deep pharmaceuticals expertise we’re confident that Materia Malta will become one of the most important production facilities in Europe’s cannabis supply chain,” he continued.
‘Carbasi Verde’ was released into the market with a potency of 21.7% THC, following successful completion of Materia Malta’s first production cycle.
“Materia has been at the forefront of Malta’s cannabis industry since we moved quickly to become a European leader in this field,” Malta Enterprise CEO Kurt Farrugia said, congratulating the company.
“We’re extremely proud to see locally produced medicinal products available to Maltese patients and are excited to continue supporting Materia’s talented team as the company expands its presence across the content,” he concluded.
Fenech & Fenech Advocates appoints Antonio Ghio as Chief Innovation and Technology Officer
Antonio Ghio is an IT Law expert and has been with the firm for the past 25 years.
‘Considerable potential’ for Malta to develop as a private equity and venture capital hub – PEVCA head
He said that private equity and venture capital play a vital role in modern, innovation-driven economies.
Nancy Pavlaki appointed Chief Financial Officer at Ramla Bay Resort
Prior to taking up the post, she worked in a number of financial positions in the hospitality industry.
Kyle Antoni Pace Cumbo appointed Chief Commercial Officer at Iniala
'I’m incredibly excited about what comes next,' he said.
